A Lancet study finds only 40% treatment success for extensively drug-resistant tuberculosis in Europe, with outcomes now ...

Recent rates of active respiratory tuberculosis (TB) in the United States are suggested to reflect immigration patterns from ...

Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published ...

This is a prospective observational study that will enroll individuals with suspected pulmonary TB and follow those with culture-confirmed, rifamycin-sensitive TB for 18 months, from the initiation of ...

A clinical drug trial conducted in five Sub-Sahara African countries shows that a shortened (four month) treatment for tuberculosis (TB) is well tolerated and may work well in subsets of TB patients, ...

Diagnosing TB in children has long been a challenge, but that is set to change. qXR from Qure.ai is the first AI-enabled ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, to less than $1 per day, primarily owing to Indian manufacturers joining in ...

Rocky Knoll Sanitorium and Hospital opened in 1926 as a state-of-the-art tuberculosis treatment center in Sheboygan County.

Maine CDC confirmed three unrelated tuberculosis cases in Portland in September 2025, part of 28 statewide cases reported that year. Genetic testing ruled out direct transmission between these ...

A team of researchers at the University of Witwatersrand are developing a system of medicine delivery at the nano scale to ...